SEC Company Response from Altimmune, Inc. (ALT) (CIK 0001326190) (ALT) — Sep 27, 2018
Altimmune, Inc. (ALT) (CIK 0001326190)
Date: Sept. 27, 2018 · CIK: 0001326190 · Accession: 0001193125-18-285783
AI Filing Summary & Sentiment
Reasoning
Letter
ALTIMMUNE, INC.
910 Clopper Road, Suite 201S
Gaithersburg, Maryland 20878
September 27,
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, DC 20549-3628
Attention: Ms. Suzanne Hayes, Assistant Director
Ms. Irene J. Paik, Attorney Adviser
Re: Registration Statement on Form S-1 (File No. 333- 226441)
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned registrant (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that the same may become effective at 5:00 p.m. (Washington D.C. time) on Thursday, September 27, 2018 or as soon as practicable thereafter.
Please contact Ori Solomon of Proskauer Rose LLP, counsel to the Company, at (617) 526-9889 if you have any questions about this letter.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
Sincerely,
ALTIMMUNE, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP ALTIMMUNE, INC. 910 Clopper Road, Suite 201S Gaithersburg, Maryland 20878 September 27, 2018 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, DC 20549-3628 Attention: Ms. Suzanne Hayes, Assistant Director Ms. Irene J. Paik, Attorney Adviser Re: Registration Statement on Form S-1 (File No. 333- 226441) Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned registrant (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that the same may become effective at 5:00 p.m. (Washington D.C. time) on Thursday, September 27, 2018 or as soon as practicable thereafter. Please contact Ori Solomon of Proskauer Rose LLP, counsel to the Company, at (617) 526-9889 if you have any questions about this letter. [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] Sincerely, ALTIMMUNE, INC. /s/ William Brown William Brown Acting Chief Financial Officer cc: Ori Solomon, Proskauer Rose LLP